Use of statistical analysis, data mining, decision analysis and cost effectiveness analysis to analyze medical data : application to comparative effectiveness of lumpectomy and mastectomy for breast cancer.

Mapping Intimacies ◽

10.18297/etd/1473 ◽

2011 ◽

Author(s):

Beatrice Ugiliweneza

Keyword(s):

Breast Cancer ◽

Data Mining ◽

Statistical Analysis ◽

Cost Effectiveness ◽

Decision Analysis ◽

Comparative Effectiveness ◽

Analysis Data ◽

Medical Data ◽

Effectiveness Analysis ◽

Data Application

Download Full-text

Decision Analysis and Cost-Effectiveness Analysis for Comparative Effectiveness Research—A Primer

Seminars in Radiation Oncology ◽

10.1016/j.semradonc.2013.08.002 ◽

2014 ◽

Vol 24 (1) ◽

pp. 14-24 ◽

Cited By ~ 8

Author(s):

David J. Sher ◽

Rinaa S. Punglia

Keyword(s):

Cost Effectiveness ◽

Decision Analysis ◽

Comparative Effectiveness Research ◽

Comparative Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Research ◽

Effectiveness Analysis

Download Full-text

A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: Patients switching within firstline agents or to Natalizumab or Fingolimod in active RRMS

10.26226/morressier.59a3eda9d462b8028d8957ad ◽

2017 ◽

Author(s):

Tim Spelman

Keyword(s):

Cost Effectiveness ◽

Real World ◽

Comparative Effectiveness ◽

Real World Data ◽

World Data ◽

Effectiveness Analysis ◽

Effectiveness Model ◽

Propensity Matching ◽

Comparative Effectiveness Analysis

Download Full-text

PCN122 COST-EFFECTIVENESS ANALYSIS OF TRASUTUZUMAB EMTANSINE VERSUS TRASTUZUMAB FOR WOMEN WITH HER2+ ADJUVANT BREAST CANCER IN FRANCE

Value in Health ◽

10.1016/j.jval.2019.09.318 ◽

2019 ◽

Vol 22 ◽

pp. S459 ◽

Cited By ~ 1

Author(s):

A. Gherardi ◽

R. Sellami ◽

B. Tehard ◽

S. Roze

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Adjuvant Breast Cancer

Download Full-text

Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2021.02.013 ◽

2021 ◽

Author(s):

Yurie Sekigami ◽

Sydney Char ◽

Cate Mullen ◽

Kathryn Huber ◽

Yu Cao ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Breast Cancer Related Lymphedema ◽

Lymph Node Transfer

Download Full-text

58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.03.072 ◽

2021 ◽

Vol 32 ◽

pp. S45

Author(s):

X. Guan ◽

H-C. Li ◽

Q-J. Chen ◽

B. Hua ◽

J-J. Li ◽

...

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Chinese Patients ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2021.1909478 ◽

2021 ◽

pp. 1-10

Author(s):

Carlos Henrique Botelho ◽

Maria Del Pilar Estevez-Diz ◽

Alessandro Gonçalves Campolina

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Early Breast Cancer ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting

Clinical Therapeutics ◽

10.1016/j.clinthera.2014.10.023 ◽

2015 ◽

Vol 37 (1) ◽

pp. 134-144 ◽

Cited By ~ 9

Author(s):

George Dranitsaris ◽

Stefan Gluck ◽

Claudio Faria ◽

David Cox ◽

Hope Rugo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Comparative Effectiveness ◽

Triple Negative ◽

Metastatic Breast ◽

Community Setting ◽

Cytotoxic Agents ◽

Effectiveness Analysis ◽

Comparative Effectiveness Analysis

Download Full-text

PCN69 Cost-Effectiveness Analysis of NOVEL Therapies for HER2+ Metastatic Breast Cancer: [FAM-] Trastuzumab Deruxtecan Versus Tucatinib Trastuzumab and Capecitabine Combination

Value in Health ◽

10.1016/j.jval.2020.08.206 ◽

2020 ◽

Vol 23 ◽

pp. S433-S434

Author(s):

G. Vondeling ◽

E. Palaka ◽

C. Livings ◽

J. Naik ◽

W. Sullivan

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cost Effectiveness ◽

Metastatic Breast ◽

Cost Effectiveness Analysis ◽

Novel Therapies ◽

Effectiveness Analysis

Download Full-text

Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3107-3 ◽

2014 ◽

Vol 147 (2) ◽

pp. 443-443 ◽

Cited By ~ 1

Author(s):

Vakaramoko Diaby ◽

Georges Adunlin ◽

Simon B. Zeichner ◽

Kiran Avancha ◽

Gilberto Lopes ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cost Effectiveness ◽

Hormone Receptor ◽

Metastatic Breast ◽

Cost Effectiveness Analysis ◽

Hormone Receptor Positive ◽

Effectiveness Analysis

Download Full-text

A Cost-Effectiveness Analysis of Palbociclib and other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

Value in Health ◽

10.1016/j.jval.2016.03.1589 ◽

2016 ◽

Vol 19 (3) ◽

pp. A150 ◽

Cited By ~ 6

Author(s):

K Bhattacharya ◽

Y Yang

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Advanced Breast Cancer ◽

Aromatase Inhibitors ◽

Cost Effectiveness Analysis ◽

Advanced Breast ◽

Effectiveness Analysis

Download Full-text